January 22, 2012
Fitch Even partner Kendrew H. Colton was quoted in an article published in the December 17, 2012, online and print editions of Chemical & Engineering News, a weekly publication of the American Chemical Society. The article, titled "Protest Over U.S. Price of AIDS Drug," discusses the response expected from the National Institutes of Health (NIH) to a petition asking NIH to override Abbott Laboratories’ patents on the AIDS drug, Norvir, and allow generic production to lower the drug’s cost.
Ken has extensive intellectual property counseling and litigation experience involving patent infringement, contract licensing disputes, copyrights, unfair competition, and trade secrets. His practice specialty is designing strategies to achieve market exclusivity and freedom to operate for clients in established and emerging chemical and biochemical technologies.
- IP Alert | USPTO Releases Latest Guidance for Evaluating Subject Matter Eligibility Under 35 U.S.C. § 101January 11, 2019 Read more
- IP Alert | USPTO Releases Guidance for Examining Computer-Implemented Functional Claim Limitations for Compliance with 35 U.S.C. § 112January 11, 2019 Read more